Sigilon Therapeutics, Inc.

NasdaqGS:SGTX Stock Report

Market Cap: US$56.5m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Sigilon Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of SGTX?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1,0320.041%
Individual Insiders1,7950.0714%
Public Companies211,1108.4%
Institutions411,21416.4%
VC/PE Firms797,72031.7%
General Public1,091,62743.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 24 shareholders own 56.59% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
31.7%
Flagship Pioneering
797,720US$17.9m0%0.91%
8.4%
Eli Lilly and Company
211,110US$4.7m0%no data
4.54%
Canada Pension Plan Investment Board
114,244US$2.6m0%no data
3.13%
FMR LLC
78,796US$1.8m-2.87%no data
2.27%
HarbourVest Partners, LLC
56,980US$1.3m0%0.33%
1.58%
Yakira Capital Management, Inc.
39,746US$893.1k0%0.29%
1.56%
State of Wisconsin Investment Board
39,202US$880.9k0%no data
0.92%
The Vanguard Group, Inc.
23,147US$520.1k0%no data
0.85%
Millennium Management LLC
21,424US$481.4k20.2%no data
0.69%
Morgan Stanley & Co. International Plc Investment Account
17,318US$389.1k647%no data
0.38%
Bridgeway Capital Management, LLC
9,615US$216.0k0%0.01%
0.13%
State Street Global Advisors, Inc.
3,176US$71.4k0%no data
0.096%
Jane Street Group, LLC, Asset Management Arm
2,426US$54.5k0%no data
0.087%
Goldman Sachs Group, Investment Banking and Securities Investments
2,199US$49.4k69.2%no data
0.071%
Deya Corzo
1,795US$40.3k0%no data
0.066%
Morgan Stanley Investment Management Inc.
1,668US$37.5k0%no data
0.041%
Tower Research Capital LLC
1,032US$23.2k9.79%no data
0.027%
Bank of America Corporation, Asset Management Arm
682US$15.3k-0.15%no data
0.01%
BlackRock, Inc.
253US$5.7k-99.7%no data
0.0088%
Lord, Abbett & Co. LLC
220US$4.9k0%no data
0.0039%
Federated Hermes, Inc.
98US$2.2k-54.6%no data
0.00028%
Wells Fargo & Company, Private Banking and Investment Banking Arm
7US$158.20%no data
0.00028%
Royal Alliance Associates, Inc., Securities Investments
7US$158.20%no data
0.00024%
Guggenheim Partners, LLC
6US$135.60%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/08/15 07:51
End of Day Share Price 2023/08/10 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sigilon Therapeutics, Inc. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Huidong WangBarclays
Thomas ShraderBTIG
Whitney IjemCanaccord Genuity